Wikidata

(Q61918430)

English

Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India

clinical trial

In more languages

Statements

title
A Phase 1, Open-Label, Dose Escalating Study to Evaluate the Safety, Tolerability, and Immunogenicity of the LEISH-111F + MPL-SE Vaccine (Recombinant Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE) in Healthy Adults In India (English)
0 references
country
India
0 references
start time
April 2007
0 references
end time
November 2008
0 references
number of participants
36
0 references
minimum age
18 year
0 references
maximum age
54 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61918430&oldid=2109070331"